Having trouble accessing articles? Reset your cache.

Inhibiting NR4A1, NR4A2 and N4RA3 in CAR Ts to enhance efficacy in solid tumors

DISEASE CATEGORY: Cancer

INDICATION: Melanoma; colorectal cancer

Mouse studies suggest inhibiting NR4A1, NR4A2 and NR4A3 in CAR T cells could

Read the full 196 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE